The
manufacture of sterile pharmaceutical product requires specific care Regarding
environment, premises and practice of the personnel. Regulations in place to be
used by the Pharmaceutical Industry give requirements on the environmental
monitoring program. With the publication of FDA Warning Letters and 483 That
form shows environmental monitoring procedure and practice of the staff belong
to top 10 of the gaps found During inspections.
Benedict
RAMOND has written an interesting article for the magazine La Vague. The article can
be found here.
Here
is an extract:
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources